Treos Bio

Biotechnology Research • London, England, United Kingdom • 11-20 Employees

Company overview

Headquarters	40-44 Newman Street, London, England, GB
Phone number	+442031417370
Website	treosbio.com
NAICS	541714
SIC	873
Keywords	Immuno-Oncology
Employees	11-20
Socials

Key Contact at Treos Bio

Gabor Molnar

Non Executive Director

Treos Bio Email Formats

Treos Bio uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@treosbio.com), used 100% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@treosbio.com	100%

About Treos Bio

Treos Bio is a clinical stage company introducing a disruptive computational technology to change the paradigm of cancer immunotherapy development by resolving the dual challenges of patient and tumor heterogeneity. We use proprietary therapeutic peptides, produced through commercially scalable processes without need for tumor biopsy, to stimulate clinically effective cancer-specific immune responses in patients predicted by our diagnostic tests to respond.

Treos Bio revenue & valuation

Annual revenue	$4,100,000
Revenue per employee	$293,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$13,200,000
Total funding	$18,499,999